Mark Richards

A Strategic Guide to PMS, eAF, ePI, eCTD 4.0. and ESMP

Devices Incorporating Tissues or Cells of Animal or Human Origin, or Their Derivatives: Data Expectations Under EU MDR

Nitrosamine Control Insights: Clarity and Control in EU Risk Assessment

PMCF Under MDR: When is a Healthcare Professional Survey Approach Justifiable?

Dental Medical Devices: Special Considerations for Clinical Evaluation Under EU MDR

MDR Article 117: What It Means — And How We Help You Get Ahead

Heavy Metals in Pharmaceuticals: A Critical Quality and Safety Imperative

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era